Related Experiment Video
Updated: Jan 10, 2026

Comparing Metastatic Clear Cell Renal Cell Carcinoma Model Established in Mouse Kidney and on Chicken Chorioallantoic Membrane
Published on: February 8, 2020
Polystyrene Microplastics Exposure Aggravates Clear Cell Renal Cell Carcinoma Progression via the NF-κB and TGF-β
Shiqi Ye1,2, Jianfeng Xiang3, Siqi Zhou4
1Department of Urology, Fudan University Shanghai Cancer Center, Department of Oncology, Shanghai Medical College, Shanghai Genitourinary Cancer Institute, Fudan University, Shanghai, 200032, China.
Polystyrene microplastics (PS-MPs) significantly increase in kidney cancer tissues, promoting clear cell renal cell carcinoma (ccRCC) growth by activating NF-κB and TGF-β pathways. This identifies PS-MPs as a risk factor and suggests new therapeutic targets.
Area of Science:
- Environmental Science
- Oncology
- Toxicology
Background:
- Polystyrene microplastics (PS-MPs) are emerging environmental contaminants.
- Their specific role in clear cell renal cell carcinoma (ccRCC) pathogenesis is largely unknown.
- Understanding PS-MPs' impact on ccRCC is crucial for public health.
Purpose of the Study:
- To investigate the presence and impact of PS-MPs in ccRCC tissues.
- To elucidate the molecular mechanisms by which PS-MPs influence ccRCC progression.
- To evaluate potential therapeutic strategies against PS-MPs-induced ccRCC.
Main Methods:
- Detection of PS-MPs in ccRCC tissues and normal adjacent tissues (NAT) using Py-GC/MS, LDIR, and SEM.
- Assessment of PS-MPs' effects on ccRCC cellular behaviors via functional assays.
- Transcriptomic analysis (RNA-seq) to identify molecular alterations.
- Investigation of signaling pathways (NF-κB, TGF-β) using immunoblotting, immunocytochemistry, and ELISA.
- Evaluation in preclinical PDO and CDX models.
Main Results:
- PS-MPs were significantly more abundant in ccRCC tissues than in NAT.
- Cytoplasmic accumulation of PS-MPs promoted malignant phenotypes in ccRCC cells.
- PS-MPs exposure activated oncogenic pathways, specifically NF-κB and TGF-β.
- Preclinical models showed PS-MPs accelerated ccRCC growth, which was mitigated by pathway inhibitors.
Conclusions:
- This study provides the first comprehensive evidence linking PS-MPs to ccRCC progression.
- PS-MPs exacerbate ccRCC by activating the NF-κB and TGF-β signaling pathways.
- PS-MPs are identified as an environmental risk factor for ccRCC, with potential therapeutic targets.
Related Concept Videos
The Tumor Microenvironment
Drugs that Stabilize Microtubules

